Lilly profit beats forecast
April 24 (Reuters) - Eli Lilly and Co on Wednesday reported higher-than-expected first-quarter earnings, helped by sales of its treatments for diabetes, depression and lung cancer.
The company said it had net income of $1.55 billion, or $1.42 per share. That compared with $1.01 billion, or 91 cents per share, in the year-earlier period.
- Rescuers scour sea for Malaysian jet lost in 'unprecedented mystery' |
- The search for missing Malaysian jet
- Mexico kills drug kingpin reported dead years ago: official
- Missing Malaysian jet may have disintegrated in mid-air: source |
- Exclusive: Malaysia plane probe narrows on mid-air disintegration - source